awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35221071-F0783229-DD2C-4B75-9476-B2486F1FAA29
Q35221071-F0783229-DD2C-4B75-9476-B2486F1FAA29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35221071-F0783229-DD2C-4B75-9476-B2486F1FAA29
The choice of first-line chronic myelogenous leukemia treatment.
P2860
Q35221071-F0783229-DD2C-4B75-9476-B2486F1FAA29
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35221071-F0783229-DD2C-4B75-9476-B2486F1FAA29
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ccbfc3e03b6d8f5167c090e511121da448954a8
P2860
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.